Skip to main content
    O

    Omada Health, Inc. Common Stock (OMDA)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $14.33
    -0.37 (-2.52%)

    Market Cap: $889.00M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Omada Health, Inc. Common Stock (OMDA) P/E Ratio & Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Omada Health, Inc. Common Stock (OMDA) trades at 36.6x trailing earnings and 2.6x sales. Its forward P/E is 43.5x. The median P/E across 7 similar companies is 35.0x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 15.9% lower over the next year. Its free cash flow yield is 2.6%.

    MultipleValue
    P/E (trailing)36.6x
    Forward P/E43.5x
    Price to sales2.6x
    Price to book3.2x
    Price to FCF39.2x
    EV/FCF28.4x
    PEGN/A
    FCF yield2.6%

    As of Nov 17, 2026

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About OMDA

    What is OMDA's forward P/E ratio?

    Omada Health, Inc. Common Stock has a forward P/E ratio of 43.5x.

    Is OMDA stock overvalued?

    GNG's valuation label for OMDA is Undervalued. Its P/E of 36.6x compares with a median of 35.0x across 7 similar companies.

    What is OMDA's price to sales ratio?

    Omada Health, Inc. Common Stock has a price to sales ratio of 2.6x.